Studies in mouse models have demonstrated that drugs targeting mt-DNA can slow tumor development without suppressing the growth of healthy cells [75], as METTL4 can cause cell arrest in the G1 phase or lead to chromosome alignment disorders, thereby controlling the cell cycle process [76]. Here, METTL4 is linked to neoplasm.